Luca Quagliata
Private Equity Investor at Xgen Venture Sgr SpA
Network origin in Luca Quagliata first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Università degli Studi di Napoli Federico II
23
| College/University | Other Consumer Services | 23 |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy.
10
| Private Company | Investment Managers | 10 |
Heidelberg University (Ohio)
2
| College/University | Other Consumer Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Luca Quagliata via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chief Executive Officer Director/Board Member Chairman | |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Chief Executive Officer Director/Board Member Private Equity Investor | |
| Sapienza University of Rome | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| SIMONE S.P.A. | Publishing: Books/Magazines | Director/Board Member Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree Masters Business Admin | |
| Politecnico di Milano | College/University | Masters Business Admin Chief Tech/Sci/R&D Officer | |
Congenia Srl
 Congenia Srl Miscellaneous Commercial ServicesCommercial Services Congenia SRL operates as pharmaceutical company, is engaged in the development of novel therapeutics for diseases associated with mitochondrial stress-induced dysfunction. The company develops small molecule drugs that target the mitochondrial permeability transition pore, a protein channel with various macromolecular components that along with mitochondrial protein p66, appears to be associated with oxidative stress-induced cell death. The company was founded in 2004 by Saverio Minucci, Pier Giuseppe Pelicci, Marco Giorgio and Paolo Bernardi and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| AZITRAPAR | Pharmaceuticals: Major | Director/Board Member | |
| Bogazici University | College/University | Undergraduate Degree | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bayes Business School | College/University | Graduate Degree | |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
AnaCap Financial Partners Ltd
 AnaCap Financial Partners Ltd Investment ManagersFinance AnaCap Financial Partners Ltd (AnaCap Financial Partners) is a Private Equity firm founded in 2005 by Joe Giannamore. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst | |
Pollen Street Capital Ltd.
 Pollen Street Capital Ltd. Investment ManagersFinance Pollen Street Capital Ltd (Pollen Street Capital) is a private equity firm founded in 1980 by Lindsey Villon McMurray. Pollen Street Capital Ltd. is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
| Leaps By Bayer /US/ | Investment Managers | Private Equity Investor | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Executive Officer | |
| ENI S.P.A | Oil Refining/Marketing | Corporate Officer/Principal | |
Associazione Italiana del Private Equity e Venture Capital
 Associazione Italiana del Private Equity e Venture Capital Investment ManagersFinance Associazione Italiana del Private Equity e Venture Capital operates as an association to promote, develop and represent institutionally the venture capital and private equity activity in Italy. The firm is an organization composed of different entities which, throughout direct investment of their own funds or through the management and advisory of independent funds (closed-end funds) are private equity and venture capital investors with the objective of purchasing, managing and divesting in unquoted companies. The company was founded in May 1986 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
| BEEWIZE S.P.A. | Advertising/Marketing Services | Director/Board Member | |
| Province of Naples | Province/State | Corporate Officer/Principal | |
Studio Legale Calesella
 Studio Legale Calesella Miscellaneous Commercial ServicesCommercial Services Studio Legale Calesella provides legal services. The private company is based in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Carnelutti Studio Legale Associato
 Carnelutti Studio Legale Associato Miscellaneous Commercial ServicesCommercial Services Carnelutti Studio Legale Associato engages in the provision of legal services. It specializes in corporate and commercial law, mergers and acquisitions (M&A) and private equity, litigation, tax, restructuring, labor, banking and finance, intellectual property, and administrative law. The company is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Eni Oil Algeria Ltd.
 Eni Oil Algeria Ltd. Integrated OilEnergy Minerals Part of Eni SpA, Eni Oil Algeria Ltd. is a British company that engages in the extraction of crude petroleum and natural gas. The company is based in London, UK. Founded in 1988, Eni Oil Algeria focuses on the exploration and production of oil and gas resources. | Integrated Oil | Director/Board Member | |
Eni Next LLC
 Eni Next LLC Investment ManagersFinance Eni Next LLC (Eni Next) is a venture capital subsidiary of Eni Petroleum Co, Inc founded in 2018. The firm is headquartered in Boston, Massachusetts.. | Investment Managers | Corporate Officer/Principal | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Director/Board Member | |
| SDA Bocconi School of Management | College/University | Masters Business Admin | |
| Università degli Studi di Roma Tor Vergata | College/University | Undergraduate Degree | |
Indaco Venture Partners SGR SpA
 Indaco Venture Partners SGR SpA Investment ManagersFinance Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
| MICROSOFT CORPORATION | Packaged Software | Corporate Officer/Principal | |
Istituto Italiano di Tecnologia
 Istituto Italiano di Tecnologia Miscellaneous Commercial ServicesCommercial Services Istituto Italiano di Tecnologia engages in the scientific research for technological development. It offers mechanical workshop that carries out advisory, construction, design, prototyping, and development activities. Its research domains include robotics, nanomaterials, technologies for life sciences (lifetech), and computational sciences. The company was founded by Giulio Tremonti and Vittorio Grilli in 2003 and is headquartered in Genoa, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree | |
| PT Accenture | Corporate Officer/Principal | ||
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SHEDIR PHARMA GROUP S.P.A. | Pharmaceuticals: Other | Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
| Aalto University | College/University | Undergraduate Degree | |
| Seco Holding Co., Inc. | Director/Board Member | ||
| AUTOSTRADE MERIDIONALI S.P.A. | Other Transportation | Director/Board Member |
Statistics
International
| Italy | 23 |
| United States | 14 |
| United Kingdom | 8 |
| Turkey | 2 |
| Norway | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 12 |
| Commercial Services | 10 |
| Finance | 8 |
| Energy Minerals | 3 |
Operational
| Director/Board Member | 68 |
| Corporate Officer/Principal | 40 |
| Undergraduate Degree | 28 |
| Private Equity Investor | 24 |
| Chief Executive Officer | 13 |
Most connected contacts
- Stock Market
- Insiders
- Luca Quagliata
- Company connections
